BamSEC and AlphaSense Join Forces
Learn More

Agios Pharmaceuticals Inc.

NASDAQ: AGIO    
Share price (1/7/25): $35.12    
Market cap (1/7/25): $2.003 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.7
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.6
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.5
from S-3ASR 61 pages Agios Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.4
from S-3ASR 59 pages Agios Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.7
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.6
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.5
from S-3ASR 61 pages Agios Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.4
from S-3ASR 59 pages Agios Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.3
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 61 pages Agios Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 59 pages Agios Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.4
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 60 pages Agios Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 56 pages Agios Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 35 pages Agios Pharmaceuticals, Inc. Second Amended and Restated Investor Rights Agreement November 16, 2011
12/34/56
EX-4
from DRS 35 pages Agios Pharmaceuticals, Inc. Second Amended and Restated Investor Rights Agreement November 16, 2011
12/34/56